Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
25 Recreation Park Dr Suite 108, Hingham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
STEMCELLS INC (to 11/15/2016), CYTOTHERAPEUTICS INC/DE (to 5/15/2000)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391 % -21.8%
Debt-to-equity 33 % +29.6%
Return On Equity -173 % -1.33%
Return On Assets -130 % +4.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.5M shares +41%
Common Stock, Shares, Outstanding 16M shares +36.4%
Entity Public Float 38.1M USD +10.5%
Common Stock, Value, Issued 161K USD +36.4%
Weighted Average Number of Shares Outstanding, Basic 14.8M shares +61.4%
Weighted Average Number of Shares Outstanding, Diluted 14.8M shares +61.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.33M USD -21.9%
General and Administrative Expense 4.18M USD -15.8%
Operating Income (Loss) -9.51M USD +19.3%
Net Income (Loss) Attributable to Parent -10.4M USD +10.1%
Earnings Per Share, Basic -0.78 USD/shares +47.3%
Earnings Per Share, Diluted -0.78 USD/shares +32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.47M USD -56.9%
Marketable Securities, Current 4M USD -4.81%
Cash, Cash Equivalents, and Short-term Investments 6.46M USD -34.9%
Other Assets, Current 1.34M USD
Assets, Current 7.14M USD -31%
Property, Plant and Equipment, Net 122K USD -32.2%
Operating Lease, Right-of-Use Asset 174K USD -52.3%
Assets 7.43M USD -31.7%
Accounts Payable, Current 178K USD -25.8%
Employee-related Liabilities, Current 725K USD -47.2%
Accrued Liabilities, Current 1.05M USD +22.6%
Liabilities, Current 1.34M USD +1.28%
Operating Lease, Liability, Noncurrent 38K USD -58.7%
Liabilities 1.38M USD -2.61%
Retained Earnings (Accumulated Deficit) -84.3M USD -14.1%
Stockholders' Equity Attributable to Parent 6.06M USD -36%
Liabilities and Equity 7.43M USD -31.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.42M USD +24.4%
Net Cash Provided by (Used in) Financing Activities 2.4M USD
Net Cash Provided by (Used in) Investing Activities -1.28M USD -145%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 16M shares +36.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD -308%
Interest Paid, Excluding Capitalized Interest, Operating Activities 40K USD +14.3%
Deferred Tax Assets, Valuation Allowance 116M USD +2.26%
Deferred Tax Assets, Gross 116M USD +2.47%
Operating Lease, Liability 231K USD -50%
Payments to Acquire Property, Plant, and Equipment 14K USD
Lessee, Operating Lease, Liability, to be Paid 277K USD -44%
Property, Plant and Equipment, Gross 639K USD +5.1%
Operating Lease, Liability, Current 110K USD -51.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48K USD -73.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD -33.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -22.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47K USD +42.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21K USD +950%
Deferred Tax Assets, Operating Loss Carryforwards 116M USD +2.1%
Operating Lease, Payments 75K USD -19.4%
Depreciation, Depletion and Amortization 28K USD +12%
Deferred Tax Assets, Net of Valuation Allowance 357K USD +213%